Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Billionaire Stanley Druckenmiller Squashed the Market in Q1 With These Top Picks

Page 1 of 2

Stanley Druckenmiller’s Duquesne Capital easily outpaced the timid Q1 market, in which the S&P 500 returned just 0.9%. The billionaire’s fund, now a family office closed to outside investors, continues to report its quarterly holdings with the SEC via Form 13F’s. In its latest filing, which disclosed its equity portfolio as of the end of 2014, Druckenmiller reported 35 long positions, 34 of which were in companies with market caps of at least $1 billion. Those 34 positions had strong weighted average returns of 7.7% during the first quarter.


Druckenmiller announced the closure of his fund to outside investors back in 2010, expressing the challenges of managing a large amount of money both in the personal toll it takes as well as in the difficulty of generating the same high returns. Our own research  also suggests this is the case and that as funds grow larger and larger and must allocate more and more of their investment dollars into large-cap stocks, their returns inevitably take a hit. That’s because their top large-cap picks simply don’t generate the same returns that their small-cap picks do, which we discovered through exhaustive research of the period between 1999 and 2012 (see the results). Since launching our small-cap strategy at the end of August 2012, which only considers funds’ top small-cap picks, the strategy has returned greater than 137% and outperformed the market by 240% during that period.

Biogen Inc (NASDAQ:BIIB) was Druckenmiller’s top pick at the end of 2014, and also a top biotech stock among billionaires as a whole. Druckenmiller was extremely bullish on Biogen Inc (NASDAQ:BIIB) during the fourth quarter, increasing his stake by 247% to 359,400 shares. That vaulted Biogen from the sixth most valuable position in his portfolio right to the top of it, with his exposure to the stock increasing to 11.96% from the 4.21% exposure he had to it at the end of the third quarter. The move certainly paid off, as Biogen Inc (NASDAQ:BIIB) had a big first quarter, returning 24.39%. Israel Englander and Paul Tudor Jones were a couple of the other billionaires invested in Biogen.

After its disastrous launch in Canada, which eventually led to it pulling out of the country completely, Target Corporation (NYSE:TGT) may not have seemed like the wisest of investments. However its stock has been white-hot since the middle of October, gaining over 35%, including 8.85% during the first quarter. The good news for Target Corporation (NYSE:TGT) is that while its Canadian operations were floundering, its much larger U.S operations were flourishing. Same-store sales have seen a big bounceback from disappointing numbers earlier in the year, and online sale have greatly improved. The skepticism from some investors could be seen heading into 2015, with two of the three largest positions in Target Corporation (NYSE:TGT) from funds in our database consisting of put options underlying shares, with one of those positions being held by billionaire Ken Griffin. Druckenmiller on the other hand had the greatest long exposure to the stock at 5.66%, with his position of 760,600 shares, which he again wisely increased during the fourth quarter, by 144%.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!